Elite Health Systems Inc. (EHSI) intrinsic value & 10-year financials
Elite Health Systems Inc. (EHSI) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 11.9% a year to $1.0M, with an average return on invested capital of 68.5%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.75
- Market cap
- $7.0M
- Revenue (FY2025)
- $1.0M
- Revenue growth (10-yr CAGR)
- -11.9%
- ROIC (10-yr avg)
- 68.5%
- Free cash flow (FY2025)
- -$2.9M
EHSI 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $1.0M | -$7.8M | — | -$2.9M | -374.9% | -442.0% |
| FY2024 | $0 | -$2.1M | — | -$1.5M | — | -793.0% |
| FY2023 | $0 | -$816.0K | -$0.17 | — | — | 2508.2% |
| FY2022 | $0 | -$1.3M | -$0.17 | — | — | -735.3% |
| FY2021 | $1.1M | -$627.0K | -$0.08 | — | -8.4% | -7.4% |
| FY2020 | $3.2M | $533.0K | $0.07 | — | 50.9% | 53.8% |
| FY2019 | $3.1M | $142.0K | — | — | 48.5% | 62.4% |
| FY2018 | $3.4M | -$421.0K | — | — | 3.8% | 3.6% |
| FY2017 | $3.4M | $538.0K | — | — | 20.2% | 21.8% |
| FY2016 | $3.2M | $536.0K | — | — | 19.1% | 13.0% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Elite Health Systems Inc. is facing top-line stagnation, with revenue contracting over the decade.
Elite Health Systems Inc. has earned high returns on invested capital, averaging 15.3% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Elite Health Systems Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Elite Health Systems Inc. is modeled at -11.9% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.93 per share.